ATA16732003A - USE OF CRUSHSTONE - Google Patents

USE OF CRUSHSTONE

Info

Publication number
ATA16732003A
ATA16732003A AT16732003A AT16732003A ATA16732003A AT A16732003 A ATA16732003 A AT A16732003A AT 16732003 A AT16732003 A AT 16732003A AT 16732003 A AT16732003 A AT 16732003A AT A16732003 A ATA16732003 A AT A16732003A
Authority
AT
Austria
Prior art keywords
crushstone
Prior art date
Application number
AT16732003A
Other languages
German (de)
Other versions
AT412528B (en
Inventor
Yelda Obuz
Original Assignee
Yelda Obuz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yelda Obuz filed Critical Yelda Obuz
Priority to AT16732003A priority Critical patent/AT412528B/en
Publication of ATA16732003A publication Critical patent/ATA16732003A/en
Priority to PCT/AT2004/000359 priority patent/WO2005041989A1/en
Application granted granted Critical
Publication of AT412528B publication Critical patent/AT412528B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT16732003A 2003-10-22 2003-10-22 Topical use of ground tartar emetic as aid to sexual intercourse, causes narrowing of the vagina AT412528B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT16732003A AT412528B (en) 2003-10-22 2003-10-22 Topical use of ground tartar emetic as aid to sexual intercourse, causes narrowing of the vagina
PCT/AT2004/000359 WO2005041989A1 (en) 2003-10-22 2004-10-21 Topical agent and use of potassium antimonyl tartrate for preparing said agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT16732003A AT412528B (en) 2003-10-22 2003-10-22 Topical use of ground tartar emetic as aid to sexual intercourse, causes narrowing of the vagina

Publications (2)

Publication Number Publication Date
ATA16732003A true ATA16732003A (en) 2004-09-15
AT412528B AT412528B (en) 2005-04-25

Family

ID=32932056

Family Applications (1)

Application Number Title Priority Date Filing Date
AT16732003A AT412528B (en) 2003-10-22 2003-10-22 Topical use of ground tartar emetic as aid to sexual intercourse, causes narrowing of the vagina

Country Status (2)

Country Link
AT (1) AT412528B (en)
WO (1) WO2005041989A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB190517241A (en) * 1905-08-25 1906-04-12 James Yate Johnson Improvements in the Production of Brown Shades on the Fibre, with, or without, White, or Coloured, Discharge Effects.

Also Published As

Publication number Publication date
WO2005041989A1 (en) 2005-05-12
AT412528B (en) 2005-04-25

Similar Documents

Publication Publication Date Title
ATE510556T1 (en) USE OF ERYTHROPOIETIN
DE50212455D1 (en) Use of dimerdiols
DE502005006470D1 (en) USE OF SULPHONYL UREA
DE502004011575D1 (en) Use of Dioldimerfettsäureestern
DE602004020156D1 (en) Management of frame bursts
DE602004019555D1 (en) HETEROCYCLIC 7-AMINOALKYLIDENYLCHINOLONE AND -NAPHTHYRIDONE
ATE356124T1 (en) HYDROXYALKYL SUBSTITUTED PYRIDO-7-PYRIMIDINE-7-ONE
ATE417842T1 (en) USE OF TRIS-SUBSTITUTED BENZOPYRANONES
DE50311406D1 (en) Use of moldings
DE602004026773D1 (en) PROCESSING OF ETHERN
DE602004023501D1 (en) SUBSTITUTED SPIROBE ZAZEPINE
DE50203046D1 (en) Use of esterquats
ATE394140T1 (en) USE OF NEW ETONOGEST RELESTERS
DE602004024640D1 (en) CLEANING OF TITANTETRACHLORIDE
ATE499348T1 (en) STABLE POLYMORPHO OF BIFEPRUNOXMESILATE
DE60330315D1 (en) ACYLFLUORIDE ACTIVATION OF CARBOXYSILYL-COATED GLASSES
DE60216986D1 (en) NEW USE OF PIPATALIN
ATA16732003A (en) USE OF CRUSHSTONE
ATE410417T1 (en) CRYSTAL MODIFICATIONS OF TRIAZINYLAMINOSTILBENES
DE602004016680D1 (en) N OF TESTS
DE60326437D1 (en) THERAPEUTIC USE OF SAPOGENINES
DE50308413D1 (en) CONTACTING NANOPEARS
ATA10092001A (en) USE OF KOMBUCHA
DE60233601D1 (en) Use of certain cyclolignans
DE502004006136D1 (en) Latching of assemblies

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee